The Prognostic Impact of Bone Marrow Micrometastases in Women with Breast Cancer

REFERENCES

• Zeidman I. The fate of circulating tumors cells I. Passage of cells through capillaries. Cancer Res 1961; 21: 38–39
   PubMed Web of Science ®Google Scholar
• Fidler I. J. Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo 21-desoxyuridine. J Natl Cancer Inst 1970; 145: 773–782
   Google Scholar
• Mansi J. L., Berger U., Easton D., et al. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 1987; 295: 1093–1096
   PubMed Web of Science ®Google Scholar
• Untch M., Harbeck N., Eiermann W. Micrometastases in bone marrow in patients with breast cancer. Br J Med 1988; 296: 290
   PubMed Web of Science ®Google Scholar
• Porro G., Menard S., Tagliabue E., et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 1988; 61: 2407–2411
   PubMed Web of Science ®Google Scholar
• Salvadori B., Squicciarini P., Rovini D., et al. Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 1990; 26: 865–867
   PubMed Web of Science ®Google Scholar
• Kirk S. J., Cooper G. G., Hoper M., Watt P. C., Roy A. D., Olding-Smee W. The prognostic signifi-cance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 1990; 16: 481–485
   PubMed Web of Science ®Google Scholar
• Cote R. J., Rosen P. P., Lesser M. L., Old L. J., Osborne M. P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749–1756
   PubMed Web of Science ®Google Scholar
• Mansi J. L., Berger U., Wilson P., Shearer R., Coombes R. C. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 1988; 139: 545–548
   PubMed Web of Science ®Google Scholar
• Funke I., Fries S., Rolle M., et al. Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int J Cancer 1996; 65: 755–761
   PubMed Web of Science ®Google Scholar
• Diel I. J., Kaufmann M., Costa S. D., et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996; 88: 1652–1664
   PubMed Web of Science ®Google Scholar
• Landys K., Persson S., Kovarik J., Hultborn R., Holmberg E. Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: results of a 20-year median follow-up. Breast Cancer Res Treat 1998; 49: 27–33
   PubMed Web of Science ®Google Scholar
• Mansi J. L., Gogas H., Bliss J. M., Gazet J. C., Berger U., Coombes R. C. Outcome of primarybreast-cancer patients with micrometastases: a long-term follow-up. Lancet 1999; 354(9174)197–202
   PubMed Web of Science ®Google Scholar
• Braun S., Pantel K., Muüller P., et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000; 342(8)525–533
   PubMed Web of Science ®Google Scholar
• Gebauer G., Fehm T., Merkle E., Beck E. P., Lang N., Jager W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol 2001; 19(16)3669–3674
   PubMed Web of Science ®Google Scholar
• Gerber B., Krause A., Muller H., et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001; 19: 960–971
   PubMed Web of Science ®Google Scholar
• Wiedswang G., Borgen E., Karesen R., et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 2003; 21(18)3469–3478
   PubMed Web of Science ®Google Scholar
• Pierga J.-Y., Bonneton C., Vincent-Salomon A., et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004; 10(4)1392–1400
   PubMed Web of Science ®Google Scholar
• Heiss M. M., Allgayer H., Gruetzner K. U., et al. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1995; 1(10)1035–1039
   PubMed Web of Science ®Google Scholar
• Braun S., Heumos I., Schlimok G., et al. ErbB2 over-expression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I III breast cancer patients. Cancer Res 2001; 61: 1890–1895
   PubMed Web of Science ®Google Scholar
• Solakoglu O., Maierhofer C., Lahr G., et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci 2002; 99(4)2246–2251
   PubMed Web of Science ®Google Scholar
• Klein C. A., Blankenstein T. J.F., Schmidt-Kittler O., et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. The Lancet 2002; 360(9334)683–689
   PubMed Web of Science ®Google Scholar
• Schmidt-Kittler O., Ragg T., Daskalakis A., et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci 2003; 100: 7737–7742
   PubMed Web of Science ®Google Scholar
• Offner S., Schmaus W., Witter K., et al. p53 mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci USA 1999; 96: 6942–6946
   PubMed Web of Science ®Google Scholar
• Gray J. W. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 2003; 4(1)4–6
   PubMed Web of Science ®Google Scholar
• Kuukasjarvi T., Karhu R., Tanner M., et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997; 57(8)1597–1604
   PubMed Web of Science ®Google Scholar
• Paget S. Distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571
   Google Scholar
• Loh E., Couch F. J., Hendricksen C., et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. J Am Med Assoc 1997; 277: 133–137
   Web of Science ®Google Scholar
• Klein C. A., Schmidt-Kittler O., Schardt J. A., Pantel K., Speicher M. R., Riethmuüller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci USA 1999; 96: 4494–4499
   PubMed Web of Science ®Google Scholar
• Braun S., Vogl* F. D., Naume B., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. NEJM 2005; 353(8)793–802
   PubMed Web of Science ®Google Scholar
• Goldhirsch A., Glick J. H., Gelber R. D., Coates A. S., Senn H. J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 2001; 19: 3817–3827
   PubMed Web of Science ®Google Scholar
• Goldhirsch A., Wood W. C., Gelber R. D., Coates A. S., Thurlimann B., Senn H.-J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21(17)3357–3365
   PubMed Web of Science ®Google Scholar
• Hermanek P. What's new in TNM?. Pathol Res Pract 1994; 190: 97–102
   PubMed Web of Science ®Google Scholar
• Hermanek P., Henson D. E., Hutter R. V., Sobin L. H. TNM Supplement 1993. Springer, Berlin 1993
   Google Scholar
• Hermanek P., Hutter R. V., Sobin L. H., Wittekind C. Classification of isolated tumor cells and micrometastases. Cancer 1999; 86: 2668–2673
   PubMed Web of Science ®Google Scholar
• Singletary S. E., Allred C., Ashley P., et al. Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 2002; 20(17)3628–3636
   PubMed Web of Science ®Google Scholar
• Wong G. Y.C., Yu Q. Q., Osborne M. P. Bone marrow micrometastasis is a significant predictor of long-term relapse-free survival for breast cancer by a non-proportional hazards model [abstr]. Breast Cancer Res Treat 2003; 82(suppl 1)S99
   Google Scholar
• Braun S., Cevatli B. S., Assemi C., et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001; 19: 1468–1475
   PubMed Web of Science ®Google Scholar
• Harbeck N., Untch M., Pache L., Eiermann W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 1994; 69: 566–571
   PubMed Web of Science ®Google Scholar
• Courtemanche D. J., Worth A. J., Coupland R. W., Rowell J. L., MacFarlane J. K. Monoclonal antibody LICR-LON-M8 does not predict the outcome of operable breast cancer. Can J Surg 1991; 34: 21–26
   PubMed Web of Science ®Google Scholar
• Singletary S. E., Larry L., Trucker S. L., Spitzer G. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 1991; 47: 32–36
   PubMed Web of Science ®Google Scholar
• Mathieu M. C., Friedman S., Bosq J., et al. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer. Breast Cancer Res Treat 1990; 15(1)21–26
   PubMed Web of Science ®Google Scholar
• Weinschenker P., Soares H. P., Otavio Clark O., Del Giglio A. Immunocytochemical detection of epithelial cells in the bone marrow of primary breast cancer patients: a metaanalysis. Breast Cancer Res Treat 2004; 87: 215–224
   PubMed Web of Science ®Google Scholar
• Funke I., Schraut W. Meta-analysis of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 1998; 16: 557–566
   PubMed Web of Science ®Google Scholar
• Hunink M. G., Wong J. B. Meta-analysis of failure-time data with adjustment for covariates. Med Decis Mak 1994; 14: 59–70
   PubMed Web of Science ®Google Scholar
• Clarke M. J., Stewart L. A. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?. Brit Med J 1994; 309(6960)1007–1010
   PubMed Web of Science ®Google Scholar
• Thurm H., Ebel S., Kentenich C., et al. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin Cancer Res 2003; 9(7)2598–2604
   PubMed Web of Science ®Google Scholar
• Braun S., Kentenich C. R.M., Janni W., et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000; 18: 80–86
   PubMed Web of Science ®Google Scholar
• Braun S., Hepp F., Kentenich C. R.M., et al. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res 1999; 5: 3999–4004
   PubMed Web of Science ®Google Scholar
• Pantel K., Enzmann T., Koüllermann J., Caprano J., Riethmuüller G., Koüllermann M. W. Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation. Int J Cancer 1997; 71: 521–525
   PubMed Web of Science ®Google Scholar
• Schlimok G., Pantel K., Loibner H., Fackler-Schwalbe I., Riethmuüller G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 1995; 31A: 1799–1803
   PubMed Web of Science ®Google Scholar
• Janni W., Rack B., Schindlbeck C., et al. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 2005; 103: 884–891
   PubMed Web of Science ®Google Scholar
• Wiedswang G., Borgen E., Køaresen R., et al. Isolated tumor cells in bone marrow 3 years after diagnosis in disease free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res 2004; 10(16)5342–5348
   PubMed Web of Science ®Google Scholar
• Cristofanilli M., Budd G. T., Ellis M. J., et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med 2004; 351(8)781–791
   PubMed Web of Science ®Google Scholar
• http://www.abcsg.at/abcsg/html_studien/mamma_offen.html
   Google Scholar